In our previous study, the Ins1+/−:Ins2−/− genetic manipulation resulted in lifelong prevention of hyperinsulinaemia [11], which precluded an assessment of whether anti-obesity effects would persist without sustained repression of insulin. The gene discussed is FOXM1; the disease is Obesity.